Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.

Research output: Contribution to journal › Article › peer-review

Keywords

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{ab7cd5e813734abf936990b08ef4cc96,

title = "Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.",

keywords = "ONCOLOGY",

author = "D. Hughes and D.A. Hughes",

year = "2005",

month = jul,

day = "1",

doi = "10.1016/j.ejca.2005.02.033",

language = "English",

volume = "41",

pages = "1655",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

number = "11",

}

TY - JOUR

T1 - Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2005/7/1

Y1 - 2005/7/1

KW - ONCOLOGY

U2 - 10.1016/j.ejca.2005.02.033

DO - 10.1016/j.ejca.2005.02.033

M3 - Article

SN - 0959-8049

VL - 41

SP - 1655

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 11

ER -